Even tough I think the likelihood of Benlysta getting approved is high, the better risk/reward is on the short side if you ask me. I will watch happily from the sidelines and root for those who suffer from Lupus to have finally have another viable option.
HGSI'rs have been talking about GSK buying them out almost as long as I have been talking about MRK buying ARIA! :)
OB, what is going on with AMRN???? It is trading horribly these days.
News 
Market Data 
Discover 
